Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL amyloidosis Treated With Bortezomib

Maria Gavriatopoulou; Μαρία Ρούσσου; Dimitrios C. Ziogas; Despina Fotiou; Magdalini Migkou; Evangelos Eleutherakis‐Papaiakovou; Ioannis Panagiotidis; Nikolaos Kanellias; Erasmia Psimenou; Elektra Papadopoulou; Constatntinos Pamboucas; Harikleia Gakiopoulou; Anna Tasidou; Stavroula Giannouli; Evangelos Terpos; Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1016/j.clml.2017.03.119

Related publications

Article2016

Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients with AL Amyloidosis Treated with Bortezomib

Efstathios Kastritis, Maria Gavriatopoulou, Μαρία Ρούσσου, Despina Fotiou, Dimitriοs Ziogas, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Ioannis Panagiotidis, Erasmia Psimenou, Elektra Papadopoulou, Constantinos Pamboucas, Efstathios Manios, Harikleia Gakiopoulou, Anna Tasidou, Stavroula Giannouli, Evangelos Terpos, Meletios A Dimopoulos

Article2017

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib

Efstathios Kastritis, Maria Gavriatopoulou, Μαρία Ρούσσου, Despina Fotiou, Dimitrios C. Ziogas, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Ioannis Panagiotidis, Nikolaos Kanellias, Erasmia Psimenou, E. Papadopoulou, Constandinos Pamboucas, Efstathios Manios, Hariklia Gakiopoulou, Argyrios Ntalianis, Anna Tasidou, Stavroula Giannouli, Evangelos Terpos, Meletios A Dimopoulos

Article2019

Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity

Efstathios Kastritis, Maria Gavriatopoulou, Despina Fotiou, Nikolaos Kanellias, Magdalini Migkou, Maria Irini Tselegkidi, Smaragdi Marinaki, Erasmia Psimenou, Ioannis Ntanasis‐Stathopoulos, Harikleia Gakiopoulou, Αριστέα-Μαρία Παπανώτα, Evangelos Terpos, Meletios A Dimopoulos

Article2007

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

Efstathios Kastritis, Αchilles Anagnostopoulos, Μαρία Ρούσσου, Savvas Toumanidis, Constantinos Pamboukas, Magdalini Migkou, Anna Tassidou, Irini Xilouri, Sossana Delibasi, Erasmia Psimenou, S. Mellou, Evangelos Terpos, J. Nanas, Meletios A Dimopoulos

Article2019

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Charikleia Gakiopoulou, Erasmia Psimenou, Marini Tselegkidi, Ourania Tsitsilonis, Ioannis P. Trougakos, Ioannis Kostopoulos, Evangelos Terpos, Meletios A Dimopoulos